1 study on PE-22-28 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| (unknown) | 2 | 99.88% | View COA → |
| Qingdao Sigma Chemical | 2 | 99.71% | View COA → |
| Peptide Gurus | 2 | 99.43% | View COA → |
Recent certificates: #12022 (99.624%) · #7300 (99.316%) · #19895 (99.612%) · #19116 (99.861%) · #19117 (99.861%) · #18691 (99.898%)
Manufacturers with published third-party certificates of analysis for PE-22-28. Open a vendor to see every batch we've verified.
This research provides fundamental insights into the mechanisms governing autophagy, a process vital for cellular health and implicated in numerous diseases, including cancer, neurodegeneration, and infectious disease…
Free, no account — handy when you're working with PE-22-28.